In the pediatric population, the most common course of pharyngitis is resolution within the first week of symptoms. When the disease lasts longer than expected, presents worsening symptoms, or a painful unilateral mass of the neck emerges, other conditions should be suspected, such as pharyngeal abscess and LS (
9,
10). Unfortunately, the latter is often only considered after the dissemination and development of potential life-threatening sepsis. In LS, primary infection is usually associated with tonsillitis, followed by spreading into the lateral pharyngeal space and soft tissues of the neck. Consequently, perivenular inflammation and thrombophlebitis occur over the course of the next 3 weeks (
11,
12).
The diagnosis of LS and LS variants is clinical and can be supported by radiologic findings in the absence of a positive culture (
9). The diagnosis is confirmed by the occurrence of thrombophlebitis of the internal jugular vein (which may extend to contiguous veins or venous sinuses) and isolation of anaerobic bacteria in cultures, namely,
F. necrophorum (
9,
10,
13). Other bacteria, such as
Arcanobacterium,
Streptococcus, and
Staphylococcus, also may act as primary agents of LS (
11). However, one-third of patients with LS have polymicrobial infections (
2,
3).
In this case, the diagnosis of LS was considered unlikely on admission; therefore, anaerobic cultures were not collected before starting antibiotic therapy, which may have compromised the results of our cultures. Nevertheless, once atypical LS was suspected, new blood cultures were collected (before starting intravenous clindamycin), but still, no bacterial growth was confirmed.
In LS and its variants, the development of thrombophlebitis increases the probability of septic embolization. The most common embolization locations are the lungs (85% to 92% of patients), causing cough, pleuritic chest pain, or hemoptysis, but other organs may be affected (
8). Severity ranges from septic shock (up to 7% of patients)/intensive care admission (58% of cases) to mild cases with no embolization. Mortality varies between 5% and 18% in the literature (
14). In this case the patient did not smoke, was not under any kind of medication (including contraceptive pill) and did not have any other known risk factors to thrombosis.
Cases of atypical LS have been reported in adults, usually involving the external jugular vein, superior ophthalmic vein, and facial vein (
7,
15-
18). Due to the rarity of this syndrome in the pediatric population, there are very few reports of atypical presentations. The most common thrombosis locations are the external jugular vein and sigmoid, cavernous, and transverse sinuses (
19,
20). To this date, no reports of LS presenting with isolated thrombophlebitis of the facial vein have been described in pediatric patients.
The management of LS and LS variants includes mainly supportive care and antibiotic therapy. The most common empiric antibiotic regimens include penicillin/beta-lactamase inhibitor or carbapenem and clindamycin or metronidazole due to beta-lactamase-producing strains and anaerobes (
9,
12,
14,
21). Metronidazole has good tissue penetration (including into the infected clot), high intracellular levels, and a favorable bioavailability profile, allowing an easy switch to oral therapy. A minimum of 3 weeks of antibiotic treatment should be completed. Some authors recommend 6 weeks to improve fibrin clot penetration (
22). The patient completed three weeks of antibiotic therapy with a favorable evolution. If collections are present, surgical drainage may be indicated (
8,
22).
Prompt treatment is associated with a favorable evolution and prognosis. Poorer outcomes are associated with delayed treatment (
2,
13). Pleuropulmonary emboli, pleural effusions, empyema, and abscesses are all potential pulmonary complications of LS (
2,
13).
Anticoagulation therapy remains a controversial matter in LS, as in another septic thrombophlebitis. Anticoagulation can induce clot destabilization, originating further septic emboli and disease dissemination. Some authors consider that thrombosis associated with LS resolves spontaneously (
23). However, no controlled trials validate this practice. Anticoagulation has been recommended when thrombosis extends into the cerebral sinuses and clots are large or bilateral or in cases of disease progression (
21,
23). In this case, due to the metastatic embolization with several pulmonary septic emboli throughout the pulmonary parenchyma, anticoagulation with low molecular weight heparin was started.
In this case, the diagnosis was extremely challenging since there were no reports of atypical LS presenting with isolated thrombophlebitis of the facial vein in pediatric patients. Moreover, the risk of life-threatening complications and the lack of pediatric guidelines regarding the approach of LS and its variants contributed to the difficult management of this patient.
In conclusion, this condition must be considered in pediatric patients with fever, dyspnea, chest pain, and a recent history of oropharyngeal infection. Anaerobic culture collections are recommended in these cases. We highlighted the importance of early recognition of LS and its atypical variants to improve prognosis.